Status:
COMPLETED
Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected Women
Lead Sponsor:
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV Infections
Eligibility:
All Genders
Brief Summary
In clinical trials being conducted throughout the world, pregnant HIV-infected women are given anti-HIV drugs before, during, and after they give birth to prevent mother-to-child transmission of HIV. ...
Detailed Description
Many HIV-infected women outside the United States enroll in clinical trials that provide them antiretroviral therapy (ART) to prevent mother-to-child transmission of HIV. However, data are limited on ...
Eligibility Criteria
Inclusion
- Infant born to HIV-1 infected mother enrolled in NIH-sponsored, international antiretroviral treatment trial AND who has had either in utero or postpartum antiretroviral exposure
- Parent or guardian willing to provide informed consent
Exclusion
- Infant with no exposure to antiretrovirals OR who received only intrapartum antiretroviral exposure
Key Trial Info
Start Date :
June 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
236 Patients enrolled
Trial Details
Trial ID
NCT00100867
Start Date
June 1 2006
End Date
May 1 2010
Last Update
April 1 2016
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
The Gaborone BHP Study Clinic
Gaborone, Botswana
2
The Molepolole BHP Study Clinic
Gaborone, Botswana
3
Instituto de Pesquisa Clinica Evandro Chagas Fiocruz, Fundacao Oswaldo Cruz
Rio de Janeiro, Brazil, 21045-900
4
Hospital dos Servidores do Estado
Rio de Janeiro, Brazil, 22261-161